Muenchener Rueckver Ges said on April 5, 2023 that its board of directors declared a regular
annual dividend of $1.25 per share.
Previously, the company paid $1.16 per share.
Shares must be purchased before the ex-div date of May 8, 2023 to qualify for the dividend.
Shareholders of record as of May 9, 2023
will receive the payment on May 25, 2023.
At the current share price of $26.37 / share,
the stock’s dividend yield is 4.75%.
Learn to Harvest Dividends
Buy Stock. Capture Dividend. Sell Stock. Repeat. This is the essence of dividend harvesting and you can
do it easily with Fintel’s Dividend Capture Calendar.
What is the Fund Sentiment?
There are 10 funds or institutions reporting positions in Muenchener Rueckver Ges.
This is a decrease
of
2
owner(s) or 16.67% in the last quarter.
Average portfolio weight of all funds dedicated to MURGY is 0.18%,
an increase
of 6.77%.
Total shares owned by institutions decreased
in the last three months by 29.75% to 2,700K shares.
Analyst Price Forecast Suggests 131.41% Upside
As of April 6, 2023,
the average one-year price target for Muenchener Rueckver Ges is $61.02.
The forecasts range from a low of $-2.50 to a high of $125.61.
The average price target represents an increase of 131.41% from its latest reported closing price of $26.37.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Muenchener Rueckver Ges
is $66,494MM.
The projected annual non-GAAP EPS
is $23.64.
What are Other Shareholders Doing?
Aristotle Capital Management
holds 2,591K shares.
In it’s prior filing, the firm reported owning 2,693K shares, representing
a decrease
of 3.92%.
The firm
increased
its portfolio allocation in MURGY by 23.91% over the last quarter.
Cornerstone Planning Group
holds 0K shares.
MPLAX – Praxis International Index Fund
holds 19K shares.
No change in the last quarter.
Pnc Financial Services Group
holds 3K shares.
In it’s prior filing, the firm reported owning 5K shares, representing
a decrease
of 69.37%.
The firm
decreased
its portfolio allocation in MURGY by 85.77% over the last quarter.
Front Row Advisors
holds 0K shares.
No change in the last quarter.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.